Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Olanzapine-induced respiratory failure.

M Mouallem1, I Wolf

  • 1Department of Medicine E, Chaim Sheba Medical Center, Tel-Aviv University, Sackler School of Medicine, Tel-Hashomer, Israel. mouallem@post.tau.ac.il

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|August 2, 2001
PubMed
Summary

Olanzapine can cause somnolence, a side effect that may lead to serious respiratory issues in elderly patients with lung disease. Careful monitoring is recommended for this vulnerable population when initiating olanzapine treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolving physician-AI relationship: a five-tier framework for integrating intelligent systems into clinical practice and medical education.

ESMO real world data and digital oncology·2026
Same author

Real-world behavioral practices of cancer patients: misconceptions compromising daily life activities.

ESMO real world data and digital oncology·2026
Same author

Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study)-Phase II data covering impact of concomitant haematological malignancies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.

ESMO open·2022
Same author

Real-life daily activity: the impact of misbeliefs on quality of life among cancer patients.

ESMO open·2022
Same author

Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process.

ESMO open·2022

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Pulmonology

Background:

  • Olanzapine is an atypical antipsychotic commonly used for treating psychiatric conditions.
  • While generally considered safe, olanzapine can cause significant somnolence, affecting up to 39% of patients at a 15 mg daily dose.

Observation:

  • A case study involving an elderly patient with pre-existing chronic lung disease is presented.
  • This patient experienced carbon dioxide (CO2) narcosis and subsequent respiratory failure after commencing olanzapine therapy.

Findings:

  • The severe sedative effects of olanzapine were identified as the likely cause of the life-threatening respiratory complication.
  • This highlights a potential risk associated with olanzapine in patients with compromised respiratory function.

Related Experiment Videos

Implications:

  • Elderly patients with chronic lung disease require vigilant observation when treated with olanzapine, particularly during the initial treatment phase.
  • This case underscores the importance of considering respiratory status when prescribing olanzapine to at-risk populations.